These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Conflict-of-interest management: efforts and insights from the Association of American Medical Colleges. Kirch DG Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S23-5; discussion S32-7. PubMed ID: 17471619 [TBL] [Abstract][Full Text] [Related]
6. Innovation and industry-academia interactions: where conflicts arise and measures to avoid them. Vagelos PR Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S12-3; discussion 16-22. PubMed ID: 17469468 [TBL] [Abstract][Full Text] [Related]
7. Medical devices and conflict of interest: unique issues and an industry code to address them. LaViolette PA Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S26-8; discussion S32-7. PubMed ID: 17469470 [TBL] [Abstract][Full Text] [Related]
8. Prologue: a case study in biomedical conflicts. Totenberg N Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S8-9; discussion 16-22. PubMed ID: 17471618 [No Abstract] [Full Text] [Related]
9. Proceedings of a national dialogue on biomedical conflicts of interest and innovation management. September 20, 2006. Cleveland, Ohio, USA. Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S3-80. PubMed ID: 17566157 [No Abstract] [Full Text] [Related]
10. Financial relationships of institutional review board members. Miller FG N Engl J Med; 2007 Mar; 356(9):965; author reply 965. PubMed ID: 17329710 [No Abstract] [Full Text] [Related]
11. Patient care vs. corporate connections: Cleveland Clinic wants to change but won't cut ties to industry. Abelson R; Pollack A N Y Times Web; 2005 Jan; ():C1, C4. PubMed ID: 15682548 [No Abstract] [Full Text] [Related]
12. Managing ethical performance in organizations: insights from the corporate world. Soule E Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S73-6; discussion S77-80. PubMed ID: 17471621 [TBL] [Abstract][Full Text] [Related]
13. Managing conflicts of interest and commitment: academic medicine and the physician's progress. Kachuck NJ J Med Ethics; 2011 Jan; 37(1):2-5. PubMed ID: 21149321 [No Abstract] [Full Text] [Related]
14. NerveCenter: Office of Inspector General warns NIH on lax COI oversight as many academic medical centers look inward. Samson K Ann Neurol; 2010 Mar; 67(3):A7-A10. PubMed ID: 20373337 [No Abstract] [Full Text] [Related]
15. Interactions of the public and private sectors in drug development: boundaries to protect scientific values while preserving innovation. Cassell GH Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S45-8; discussion S51-9. PubMed ID: 17469473 [TBL] [Abstract][Full Text] [Related]
16. Beyond disclosure: the necessity of trust in biomedical research. Kahn JP Cleve Clin J Med; 2007 Mar; 74 Suppl 2():S49-50; discussion S51-9. PubMed ID: 17469474 [TBL] [Abstract][Full Text] [Related]
17. Fighting graft--it's academic. Medical centers must embrace conflict rules: critics. Romano M Mod Healthc; 2006 Jan; 36(5):8-10. PubMed ID: 16479773 [No Abstract] [Full Text] [Related]
18. Entrepreneurship in the medical academy: possibilities and challenges in commercialization of research discoveries. Loscalzo J Circulation; 2007 Mar; 115(12):1504-7. PubMed ID: 17389277 [No Abstract] [Full Text] [Related]
19. Conflicts of interest at the NIH--resolving the problem. Steinbrook R N Engl J Med; 2004 Sep; 351(10):955-7. PubMed ID: 15342801 [No Abstract] [Full Text] [Related]